Who
Adam R. Levy
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, NexGel.
In numbers
- Trades disclosed
- 49
- Buys
- 2
- Sells
- 25
- Bought
- $12K
- Sold
- $162K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 17 Feb 2020
- Last trade
- 23 Jul 2026
- Last filed
- 29 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 23 Jul 2026filed 29 Jul 2026 | NXGL NexGeloption or derivative · Medical Devices | SEC FORM 4 Code A | —160,000 at $0.00 | filing |
| 23 Jul 2026filed 29 Jul 2026 | NXGL NexGeloption or derivative · Medical Devices | SEC FORM 4 Code A | —160,000 at $0.00 | filing |
| 23 Jun 2026filed 23 Jun 2026 | NXGL NexGelMedical Devices | SEC FORM 4 Sold | $2,9675,000 at $0.5933 | filing |
| 23 Jun 2026filed 23 Jun 2026 | NXGL NexGelMedical Devices | SEC FORM 4 Sold | $2,9505,000 at $0.59 | filing |
| 18 Jun 2026filed 23 Jun 2026 | NXGL NexGelMedical Devices | SEC FORM 4 Sold | $3,5536,000 at $0.5921 | filing |
| 18 Jun 2026filed 23 Jun 2026 | NXGL NexGelMedical Devices | SEC FORM 4 Sold | $3,5406,000 at $0.59 | filing |
| 11 Jun 2026filed 15 Jun 2026 | NXGL NexGelMedical Devices | SEC FORM 4 Sold | $1,8413,000 at $0.6136 | filing |
| 11 Jun 2026filed 15 Jun 2026 | NXGL NexGelMedical Devices | SEC FORM 4 Sold | $1,8303,000 at $0.61 | filing |
| 8 Jun 2026filed 9 Jun 2026 | NXGL NexGelMedical Devices | SEC FORM 4 Sold | $1,6413,000 at $0.547 | filing |
| 8 Jun 2026filed 9 Jun 2026 | NXGL NexGelMedical Devices | SEC FORM 4 Sold | $1,6503,000 at $0.55 | filing |
| 4 Jun 2026filed 9 Jun 2026 | NXGL NexGelMedical Devices | SEC FORM 4 Sold | $1,7813,000 at $0.5936 | filing |
| 4 Jun 2026filed 9 Jun 2026 | NXGL NexGelMedical Devices | SEC FORM 4 Sold | $1,7703,000 at $0.59 | filing |
| 1 Jun 2026filed 3 Jun 2026 | NXGL NexGelMedical Devices | SEC FORM 4 Sold | $1,1722,000 at $0.5859 | filing |
| 1 Jun 2026filed 3 Jun 2026 | NXGL NexGelMedical Devices | SEC FORM 4 Sold | $1,1802,000 at $0.59 | filing |
| 29 May 2026filed 29 May 2026 | NXGL NexGelMedical Devices | SEC FORM 4 Sold | $1,8013,000 at $0.6003 | filing |
| 29 May 2026filed 29 May 2026 | NXGL NexGelMedical Devices | SEC FORM 4 Sold | $1,8003,000 at $0.60 | filing |
| 28 May 2026filed 29 May 2026 | NXGL NexGelMedical Devices | SEC FORM 4 Sold | $4,2417,000 at $0.6058 | filing |
| 28 May 2026filed 29 May 2026 | NXGL NexGelMedical Devices | SEC FORM 4 Sold | $4,2707,000 at $0.61 | filing |
| 27 May 2026filed 29 May 2026 | NXGL NexGelMedical Devices | SEC FORM 4 Sold | $1,7933,000 at $0.5975 | filing |
| 27 May 2026filed 29 May 2026 | NXGL NexGelMedical Devices | SEC FORM 4 Sold | $1,8003,000 at $0.60 | filing |
News
No headline names them, or the companies they trade most, lately.